Lipocine (LPCN) Treasury Shares (2012 - 2025)
Lipocine's (LPCN) quarterly Treasury Shares came in at $40712.0 in Q4 2025, little changed YoY from $40712.0 in Q4 2024, and little changed on a QoQ basis from $40712.0 in Q3 2025.
Lipocine (LPCN) Treasury Shares (2012 - 2025) Analysis & Trends
Lipocine (LPCN) has 12 years of Treasury Shares data on file, last reported at $40712.0 in Q4 2025.
- Quarterly Treasury Shares changed 0.0% year-over-year to $40712.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $40712.0 (changed 0.0% YoY) and the FY2025 annual result came in at $40712.0, changed 0.0% from the prior year.
- Treasury Shares was little changed at $40712.0 in Q4 2025, from $40712.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $1.1 million in Q1 2021 to a low of $336.0 in Q4 2023.
- A 5-year average of $299204.2 and a median of $56897.5 in 2022 frame the typical range for Treasury Shares.
- The widest YoY moves for Treasury Shares: up 0.0% in 2021, down 0.0% in 2021.
- Tracing LPCN's Treasury Shares over 5 years: stood at $40712.0 in 2021, then changed by 0.0% to $40712.0 in 2022, then changed by 0.0% to $40712.0 in 2023, then changed by 0.0% to $40712.0 in 2024, then changed by 0.0% to $40712.0 in 2025.
- The last three Treasury Shares figures came in at $40712.0 (Q4 2025), $40712.0 (Q3 2025), and $40712.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Lipocine | 11.15 Mn | -12.76 Mn | - | 336.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 40,712.00 |
| Dec 31, 2025 | 40,712.00 |
| Dec 31, 2025 | 18,137.00 |
| Dec 31, 2025 | 18,137.00 |
| Sep 30, 2025 | 18,137.00 |
| Sep 30, 2025 | 18,137.00 |
| Sep 30, 2025 | 40,712.00 |
| Sep 30, 2025 | 40,712.00 |
| Jun 30, 2025 | 40,712.00 |
| Jun 30, 2025 | 19,346.00 |
| Jun 30, 2025 | 19,346.00 |
| Jun 30, 2025 | 40,712.00 |
| Mar 31, 2025 | 19,346.00 |
| Mar 31, 2025 | 19,346.00 |
| Mar 31, 2025 | 40,712.00 |
| Mar 31, 2025 | 40,712.00 |
| Dec 31, 2024 | 336.00 |
| Dec 31, 2024 | 336.00 |
| Dec 31, 2024 | 40,712.00 |
| Dec 31, 2024 | 40,712.00 |